melatonin has been researched along with perindopril in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liskova, IuV; Salikova, SP; Stadnikov, AA | 1 |
Bhat, SA; Goel, R; Hanif, K; Nath, C; Shukla, R | 1 |
2 other study(ies) available for melatonin and perindopril
Article | Year |
---|---|
[Extracellular matrix remodeling myocardium of the left ventricle rats with experimental heart failure after perindopril and melatonin administration].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Disease Models, Animal; Extracellular Matrix; Heart Failure; Heart Ventricles; Male; Matrix Metalloproteinase 1; Melatonin; Models, Cardiovascular; Perindopril; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1; Treatment Outcome; Ventricular Remodeling | 2014 |
Perindopril Attenuates Lipopolysaccharide-Induced Amyloidogenesis and Memory Impairment by Suppression of Oxidative Stress and RAGE Activation.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Brain; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraventricular; Lipopolysaccharides; Male; Maze Learning; Melatonin; Memory Disorders; Oxidative Stress; Peptide Fragments; Perindopril; Rats; Rats, Inbred SHR; Receptor for Advanced Glycation End Products; Time Factors | 2016 |